- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 307/06 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 307/06
Total number of patents in this class: 82
10-year publication summary
|
5
|
6
|
5
|
9
|
6
|
8
|
6
|
4
|
6
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| National University Corporation Hokkaido University | 1332 |
3 |
| Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen | 295 |
3 |
| BASF SE | 20387 |
2 |
| AstraZeneca AB | 2961 |
2 |
| Arbutus Biopharma Corporation | 189 |
2 |
| Oy Granula AB Ltd | 28 |
2 |
| Teva Pharmaceuticals International GmbH | 382 |
2 |
| Thomas Swan & Co. Ltd. | 23 |
2 |
| Certa Therapeutics Pty. Ltd. | 14 |
2 |
| F. Hoffmann-La Roche AG | 7939 |
1 |
| Shell Internationale Research Maatschappij B.V. | 3721 |
1 |
| The Regents of the University of California | 19493 |
1 |
| Merck Sharp & Dohme Corp. | 2219 |
1 |
| ExxonMobil Research And Engineering Company | 2675 |
1 |
| Merck Patent GmbH | 5847 |
1 |
| Syngenta Participations AG | 3033 |
1 |
| Amgen Inc. | 3897 |
1 |
| Evonik Degussa GmbH | 1557 |
1 |
| BASF AG | 771 |
1 |
| Glaxosmithkline Intellectual Property Development Limited | 737 |
1 |
| Other owners | 51 |